| Literature DB >> 19864674 |
Bart Ferwerda1, Gerben Ferwerda, Theo S Plantinga, Janet A Willment, Annemiek B van Spriel, Hanka Venselaar, Clara C Elbers, Melissa D Johnson, Alessandra Cambi, Cristal Huysamen, Liesbeth Jacobs, Trees Jansen, Karlijn Verheijen, Laury Masthoff, Servaas A Morré, Gert Vriend, David L Williams, John R Perfect, Leo A B Joosten, Cisca Wijmenga, Jos W M van der Meer, Gosse J Adema, Bart Jan Kullberg, Gordon D Brown, Mihai G Netea.
Abstract
Mucocutaneous fungal infections are typically found in patients who have no known immune defects. We describe a family in which four women who were affected by either recurrent vulvovaginal candidiasis or onychomycosis had the early-stop-codon mutation Tyr238X in the beta-glucan receptor dectin-1. The mutated form of dectin-1 was poorly expressed, did not mediate beta-glucan binding, and led to defective production of cytokines (interleukin-17, tumor necrosis factor, and interleukin-6) after stimulation with beta-glucan or Candida albicans. In contrast, fungal phagocytosis and fungal killing were normal in the patients, explaining why dectin-1 deficiency was not associated with invasive fungal infections and highlighting the specific role of dectin-1 in human mucosal antifungal defense. 2009 Massachusetts Medical SocietyEntities:
Mesh:
Substances:
Year: 2009 PMID: 19864674 PMCID: PMC2773015 DOI: 10.1056/NEJMoa0901053
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245